GEN Exclusives

More »

GEN News Highlights

Back to Item »

Rentschler to Manufacture Kenta’s Human mAb against MRSA for Clinical Trials

Company will leverage Kenta’s hybridoma cell line and expects to use single-use bioreactors for production.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Stopping Research Fraud

What is the best approach to curbing scientific misconduct and outright fraud?